Factors influencing attitudes toward xenotransplantation clinical trials: A report of focus group studies.
Daniel J HurstLuz A PadillaDavid K C CooperWayne ParisPublished in: Xenotransplantation (2021)
Overall, various stakeholders accepted XTx as a clinical option. However, there were ethical, social, and physical concerns raised. Future studies exploring the development of education strategies that may help alleviate concerns related to XTx before it becomes a clinical alternative are needed among the general public, potential XTx candidates, and their family members.